Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Azelis Group N.V. (AZE.BR)
EUR10.93
-0.04 (-0.36%)
BE BRU Basic Materials Chemicals - Specialty
Address
Posthofbrug 12 2600
Antwerp, BE
Antwerp, BE
CEO
Anna Bertona
Website
azelis.com
IPO
2021-09-17
ISIN BE0974400328
Also trades on
Euronext Brussels · AZE.BR (EUR)
Other OTC · AZLGF (USD)
Description
Azelis Group NV functions as a global distributor, supplying specialized chemicals and food ingredients. The company's operations extend across a diverse range of life science sectors, including personal care, pharmaceuticals, food and wellness products, specialized agricultural and horticultural solutions, and both homecare and industrial chemicals. Furthermore, Azelis provides materials for the industrial chemicals industry, encompassing applications like CASE (Coatings, Adhesives, Sealants, Elastomers), rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper. Established in 1996, Azelis Group NV is headquartered in Antwerp, Belgium, and operates as a subsidiary of Akita I S.À R.L.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR10.93
-0.04 (-0.36%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
485.7K
Beta
0.51
Float Shares
210.56M
Free Float %
86.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.90% | -4.32% | -12.63% | +17.32% | +6.08% | +5.40% | -32.36% | -57.15% | -64.80% | -64.80% | -64.80% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
10.93
DCF (Unlevered)
62.39
+470.8%
DCF (Levered)
103.78
+849.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
57% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 5 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.66
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-3.0% Q4'25: -2.9% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-37.8% Q4'25: -60.0% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.3% ★ Q4'25: +11.2% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+7.1% Q4'25: +5.8% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+4.2% Q4'25: +6.1% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%-0.8% ★ Q4'25: -3.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.79× Q4'25: 2.77× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 12 EPS Ana. |
Dec 2027 10 Rev. Ana. 12 EPS Ana. |
Dec 2028 8 Rev. Ana. 8 EPS Ana. |
Dec 2029 7 Rev. Ana. 6 EPS Ana. |
Dec 2030 7 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.83B
est: 2.77B (+2.2%)
|
4.12B
est: 4.08B (+1.2%)
|
4.15B
est: 4.16B (-0.1%)
|
4.24B
est: 4.23B (+0.2%)
|
4.11B
est: 4.14B (-0.8%)
|
4.17B
4.06B – 4.26B
+0.6% YoY
|
4.32B
4.19B – 4.50B
+3.7% YoY
|
4.52B
4.51B – 4.52B
+4.5% YoY
|
4.68B
4.56B – 4.83B
+3.7% YoY
|
5.19B
5.05B – 5.36B
+10.9% YoY
|
| EBITDA |
229.48M
est: 273.85M (-16.2%)
|
451.78M
est: 403.44M (+12.0%)
|
445.70M
est: 513.90M (-13.3%)
|
477.01M
est: 522.77M (-8.8%)
|
418.83M
est: 512.09M (-18.2%)
|
515.27M
502.51M – 526.74M
+0.6% YoY
|
534.13M
518.45M – 556.26M
+3.7% YoY
|
558.42M
558.10M – 558.74M
+4.5% YoY
|
579.11M
563.41M – 597.63M
+3.7% YoY
|
642.22M
624.82M – 662.76M
+10.9% YoY
|
| EBIT |
170.10M
est: 210.31M (-19.1%)
|
367.04M
est: 309.84M (+18.5%)
|
344.61M
est: 331.75M (+3.9%)
|
362.08M
est: 337.47M (+7.3%)
|
291.62M
est: 330.58M (-11.8%)
|
332.63M
324.39M – 340.03M
+0.6% YoY
|
344.80M
334.68M – 359.09M
+3.7% YoY
|
360.49M
360.28M – 360.69M
+4.5% YoY
|
373.84M
363.71M – 385.80M
+3.7% YoY
|
414.58M
403.35M – 427.84M
+10.9% YoY
|
| Net Income |
67.76M
est: 137.35M (-50.7%)
|
213.19M
est: 295.84M (-27.9%)
|
177.70M
est: 169.07M (+5.1%)
|
180.69M
est: 233.89M (-22.7%)
|
111.19M
est: 182.44M (-39.1%)
|
157.84M
131.91M – 242.99M
-13.5% YoY
|
182.52M
145.18M – 276.08M
+15.6% YoY
|
193.62M
179.21M – 273.00M
+6.1% YoY
|
286.44M
276.35M – 298.35M
+47.9% YoY
|
357.75M
345.15M – 372.62M
+24.9% YoY
|
| SGA |
147.95M
est: 117.03M (+26.4%)
|
158.76M
est: 172.42M (-7.9%)
|
166.77M
est: 185.33M (-10.0%)
|
174.97M
est: 188.53M (-7.2%)
|
208.30M
est: 184.68M (+12.8%)
|
185.83M
181.22M – 189.96M
+0.6% YoY
|
192.63M
186.97M – 200.61M
+3.7% YoY
|
201.39M
201.27M – 201.51M
+4.5% YoY
|
208.85M
203.19M – 215.53M
+3.7% YoY
|
231.61M
225.34M – 239.02M
+10.9% YoY
|
| EPS |
0.29
est: 0.56 (-48.5%)
|
0.91
est: 1.22 (-25.3%)
|
0.74
est: 0.69 (+6.6%)
|
0.74
est: 0.96 (-23.3%)
|
0.46
est: 0.74 (-38.1%)
|
0.74
0.55 – 1.01
-0.7% YoY
|
0.83
0.60 – 1.14
+12.0% YoY
|
0.90
0.74 – 1.13
+8.5% YoY
|
1.19
1.14 – 1.23
+32.0% YoY
|
1.48
1.43 – 1.54
+24.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
484.11M
OE per share TTM
2.01
Owner's Yield
20.76%
Maintenance CapEx ratio
33.24%
Maint CapEx / Avg PPE
4.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 80 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi BEL 20 UCITS ETF Dist BEL.BR | 1.51% | 1.21M | 0.50% |
| 2 | iShares MSCI Belgium ETF EWK | 1.28% | 2.04M | 0.49% |
| 3 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.49% | 3.45M | 0.40% |
| 4 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.46% | 4.81M | 0.58% |
| 5 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.45% | 3.31M | 0.33% |
| 6 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.25% | 1.94M | 0.30% |
| 7 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.21% | 730.6K | 0.23% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.21% | 730.6K | 0.23% |
| 9 | iShares MSCI Europe Small-Cap ETF IEUS | 0.18% | 311.7K | 0.41% |
| 10 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.17% | 5.77M | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
67.5K
Shares Outstanding
243.51M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anna Bertona | Group Chief Executive Officer & Executive Director | 964.7K | female |
| Benoit Fritz | Chief Executive Officer of Asia Pacific | — | male |
| Boris Cambon-Lalanne | Group CFO & Director | — | male |
| Evy Hellinckx | Chief Executive Officer of EMEA | — | female |
| Gerrit De Vos | Group General Counsel, Chief Compliance Officer & Company Secretary | — | male |
| Karine Parent | Group Human Resources Director | — | female |
| Pamela Antay | Senior Vice President of Equity & Credit Relations | — | female |
| Todd Cottrell | Chief Executive Officer of Americas | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AZE.BR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
